SCHEMBL8925834

SCHEMBL8925834

CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](OC(=O)/C=C/c1ccccc1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 1.00
ELANE P08246 2/20 0.72
MAPT P10636 4/20 0.68
NPSR1 Q6W5P4 2/20 0.68
KDM4E B2RXH2 1/20 0.68
GAA P10253 1/20 0.68
XBP1 P17861 1/20 0.68
KMT2A Q03164 3/20 0.61
MEN1 O00255 2/20 0.61
HTT P42858 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MAPK1 P28482 2/20 0.53
CYP19A1 P11511 2/20 0.49
ABCB1 P08183 2/20 0.46
MCL1 Q07820 1/20 0.45
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
ACP1 P24666 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4237838 1.00 CYP2C19 (1.00) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL28551481 1.00 CYP2C19 (1.00) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL16710294 1.00 CYP2C19 (1.00) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL31211469 0.89 CYP2C19 (0.80) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL29583383 0.89 CYP2C19 (0.80) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL29690272 0.89 CYP2C19 (0.80) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL5048033 0.89 CYP2C19 (0.80) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL5048036 0.89 CYP2C19 (0.80) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL5042773 0.88 CYP2C19 (0.79) CYP2C19ELANEMAPTNPSR1KDM4E
SCHEMBL5042776 0.88 CYP2C19 (0.79) CYP2C19ELANEMAPTNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112684073-B Method for simultaneously detecting contents of two volatile components in metabolism of gold microcapsule prototype 健民药业集团股份有限公司 2022-07-08 CN claimed
CN-112684073-A Method for simultaneously detecting contents of two volatile components in metabolism of gold microcapsule prototype 健民药业集团股份有限公司 2021-04-20 CN claimed
CN-110840875-A Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2020-02-28 CN claimed
JP-9124474-A None JP disclosed
CN-119184087-A Application of cinnamic acid terpene ester derivatives in prevention and treatment of bacterial wilt 南京中医药大学翰林学院 2024-12-27 CN disclosed
CN-119184087-A Application of cinnamic acid terpene ester derivatives in prevention and treatment of bacterial wilt 南京中医药大学翰林学院 2024-12-27 CN disclosed
CN-112358913-B Method and device for processing liquidambar by liquid precipitation separation of liquefied gas 广西民族大学 2023-11-03 CN disclosed
CN-112684073-B Method for simultaneously detecting contents of two volatile components in metabolism of gold microcapsule prototype 健民药业集团股份有限公司 2022-07-08 CN disclosed
CN-110840875-B Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2022-04-05 CN disclosed
CN-110840875-B Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2022-04-05 CN disclosed
CN-110840875-B Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2022-04-05 CN disclosed
CN-112684073-A Method for simultaneously detecting contents of two volatile components in metabolism of gold microcapsule prototype 健民药业集团股份有限公司 2021-04-20 CN disclosed
CN-112684073-A Method for simultaneously detecting contents of two volatile components in metabolism of gold microcapsule prototype 健民药业集团股份有限公司 2021-04-20 CN disclosed
CN-112358913-A Method and device for processing liquidized gas through liquid precipitation and separation 广西民族大学 2021-02-12 CN disclosed
CN-110840875-A Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2020-02-28 CN disclosed
CN-110840875-A Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2020-02-28 CN disclosed
CN-110840875-A Application of borneol cinnamate in preparing medicine for treating hyperplasia of mammary glands 健民药业集团股份有限公司 2020-02-28 CN disclosed
JP-H09124474-A SUPPRESSANT FOR MELANOGENESIS AND DERMAL PREPARATION FOR EXTERNAL USE POLA CHEM IND INC 1997-05-13 JP disclosed